Home NDC 68210-5004-2 MULTI-SYMPTOM DAYTIME
Product NDC 68210-5004
Requested package NDC 68210-5004-2
11-digit product format 682105004
Labeler code 68210
Product ID 68210-5004_ef6cca73-5859-4438-e053-2a95a90aea21
Type HUMAN OTC DRUG
Nonproprietary name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE
Dosage form CAPSULE, LIQUID FILLED
Route ORAL
Labeler SPIRIT PHARMACEUTICALS LLC
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2022-12-09
Marketing end 0000-00-00
Substance ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
Active strength 325 mg/1; mg/1; mg/1
Pharmacologic classes Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 3 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68210-5004 68210-5004-2 D Discontinued by firm excluded / ndc_excluded.zip ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68210-5004 68210-5004-2 D Discontinued by firm excluded / ndc_excluded.zip 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68210-5004 68210-5004-2 D Discontinued by firm excluded / ndc_excluded.zip 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68210-5004-1 MULTI-SYMPTOM DAYTIME 2 in 1 CARTON CAPSULE, LIQUID FILLED 2 8 68210-5004-1 MULTI-SYMPTOM DAYTIME 8 in 1 BLISTER PACK CAPSULE, LIQUID FILLED 8 8 68210-5004-2 MULTI-SYMPTOM DAYTIME 2 in 1 CARTON CAPSULE, LIQUID FILLED 2 8 68210-5004-2 MULTI-SYMPTOM DAYTIME 12 in 1 BLISTER PACK CAPSULE, LIQUID FILLED 12 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68210-5004 MULTI-SYMPTOM DAYTIME (ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [SPIRIT PHARMACEUTICALS LLC] 8 Legacy NDC, 4 package rows 20250101_336dfeae-828c-4721-b8b4-2ab8716e99e2.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68210-5004-2 68210500402 2 BLISTER PACK in 1 CARTON (68210-5004-2) > 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK 2 blister pack 2022-12-09 0000-00-00 No No Current